MTOR and mucositis: Others have demonstrated that treatment with the mTOR inhibitor rapamycin prevented the increase in SA-β-gal activity in cells exposed to DNA-damaging agents [5,43,44] and protected mice from radiation-induced mucositis in vivo [45].